Compositions And Methods For Delivering Tetrahydrocannabinol And Ketone Bodies
Disclosed herein are “ketannabis” (or “ketonnabis”) compositions including a combination of: (1) tetrahydrocannabinol (THC); (2) a ketone body component such as beta-hydroxybutyrate (BHB) and/or acetoacetate; and (3) a dietetically or pharmaceutically acceptable carrier. Also disclosed herein are methods of using such ketannabis compositions for producing desired physiological effects. The ketannabis compositions beneficially enhance the euphoric effects of THC without aggravating common side effects or even acting to reduce common side effects such as anxiety, disruption of short-term memory, appetite increases, heart rate increases, and blood pressure changes.
Claim CLM-00017. 17. A method for administering ketone bodies and tetrahydrocannabinol (THC) to a mammal, comprising:
administering a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; administering a THC component and the ketone body component raising blood ketone level in the mammal.
Claim CLM-00019. 19. (canceled)
Claim CLM-00022. 22. (canceled)
Claim CLM-00023. 23. (canceled)
Claim CLM-00025. 25. (canceled)
Claim CLM-00046. 46. A method for promoting euphoric effects in a mammal, the method comprising:
administering a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; administering a THC component; and the administering of the ketone body component and the THC component provides one or both of
promoting euphoric effects in the mammal to a greater degree than a composition containing the same amount of THC but without a ketone body component, orpromoting euphoric effects in the mammal while maintaining or reducing negative side effects as compared to a composition containing the same amount of THC but without a ketone body component.
Claim CLM-00049. 49. A method for promoting ketosis in a mammal, the method comprising:
administering a ketone body component selected from beta-hydroxybutyrate (BHB) salts, BHB esters, BHB acid, acetoacetate salts, acetoacetate esters, acetoacetic acid, and combinations thereof; administering a THC component; and the administering of the ketone body component and the THC component induces sustained ketosis in the mammal with reduced symptoms of at least one of hypoglycemia, keto flu, or depression relative to a ketone body composition omitting THC.
